N-(Benzo[d][1,3]dioxol-5-yl)-1-(2-(2-oxopyrrolidin-1-yl)benzoyl)piperidine-4-carboxamide

Catalog No. :
ACNRBY094
CAS No. :
924254-69-3
Molecular Formula :
C24H25N3O5
Molecular Weight :
435.48

IUPAC Name:N-(benzo[d][1,3]dioxol-5-yl)-1-(2-(2-oxopyrrolidin-1-yl)benzoyl)piperidine-4-carboxamide

N-(Benzo[d][1,3]dioxol-5-yl)-1-(2-(2-oxopyrrolidin-1-yl)benzoyl)piperidine-4-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(Benzo[d][1,3]dioxol-5-yl)-1-(2-(2-oxopyrrolidin-1-yl)benzoyl)piperidine-4-carboxamide
IUPAC NameN-(benzo[d][1,3]dioxol-5-yl)-1-(2-(2-oxopyrrolidin-1-yl)benzoyl)piperidine-4-carboxamide
Molecular FormulaC24H25N3O5
Molecular Weight435.48
SMILESO=C(C1CCN(C(C2=CC=CC=C2N3C(CCC3)=O)=O)CC1)NC4=CC=C(OCO5)C5=C4
InChI KeyCJIZIIWTTQYZKV-UHFFFAOYSA-N
Synonym4-Piperidinecarboxamide, N-1,3-benzodioxol-5-yl-1-[2-(2-oxo-1-pyrrolidinyl)benzoyl]-
CAS No.924254-69-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACNRBY094 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYCPW248 route compound structure diagram
    ACYCPW2482620-45-3
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNRBY094 route product structure diagram
    ACNRBY094924254-69-3
Inquiry

2. ACNRBY094 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNRBY094 route product structure diagram
    ACNRBY094924254-69-3
Inquiry

Comments (0)